company management is one aspect of how successful the company will be in the future and no doubt that BAL's SP is taking a hit but it shouldn't be the only criteria when investing.
At the moment, I figured that BAL has a higher chance to improve its SP by a higher margin this time year, compared to BKL.
ie: Will BKL be worth $360 this time next year? or BAL to go to $20?
One of Warren Buffet's quote
“I try to buy stock in businesses that are so wonderful that an idiot can run them because sooner or later, one will.”
Maybe L.McBain is an idiot (which I don't think she is) but these kind of sentiment usually gets forgotten after a few months. Similar to all the hype (opposite of the spectrum) when people bought in at much higher prices a few months ago (whether its BKL @$220+ , A2M @2.50+ or BAL @$16+)...
How fortunes change in a few months...
- Forums
- ASX - By Stock
- BAL
- New information
New information, page-14
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online